Alvotech, Teva secure U.S. license date for proposed Stelara biosimilarAccording to the settlement agreement, AVT04 (ustekinumab) can be marketed in the United States, subject to regulatory approval, no later than Feb. 21, 2025. Techdow USA launches generic LovenoxEnoxaparin, a low molecular weight heparin, is an anticoagulant that helps to prevent thrombosis. Camber intros generic Mexitil Mexiletine hydrochloride capsules are used to treat documented ventricular arrhythmias, such as sustained ventricular tachycardia, that in the judgment of a physician, is life-threatening. Dr. Reddy’s completes Phase I study of proposed tocilizumab biosimilar Dr. Reddy’s is developing the proposed tocilizumab biosimilar as intravenous and subcutaneous formulations. Lupin intros generic Prezista Prezista is a HIV-1 medicine used with Norvir (ritonavir) and other antiretroviral medicines to treat HIV-1 infection in adults. Mark Cuban Cost Plus Drug Company partners with Coherus to offer Humira biosimilar Mark Cuban Cost Plus Drug Company plans to offer Yusimry to its customers for $569.27, plus dispensing and shipping fees starting in July 2023. Alembic debuts generic Tarceva Erlotinib tablets are indicated for treating metastatic non-small cell lung cancer patients with tumors with specific growth factor mutations. Sandoz to move to permanent headquarters in central Basel in mid-2024 Sandoz expects to move from the Novartis Campus to its new headquarters in mid-2024. Lupin gains FDA OK for 2 generics The FDA has approved obeticholic acid tablets, 5 mg and 10 mg, which is a generic of Intercept’s Ocaliva. Fresenius Kabi launches generic Zemuron Rocuronium Bromide injection is part of Fresenius Kabi's +RFID portfolio of smart-labeled medications. First Previous 55 56 57 58 59 Next Last
